A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Her injuries have left her with paralysis in her right leg, weakness in her left leg and some degree of paralysis in both ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Nerve cells in the spinal cord do not regenerate easily and scar tissue forms quickly, blocking the regrowth of nerve fibers. Current treatments for SCI focus on managing symptoms, preventing further ...

Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, focusing on innovative treatments. MISSION VIEJO, CALIFORNIA / ACCESS Newswire / ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

Virginia Macari-Smurfit has revealed she underwent “major lifesaving surgery” on her spine but is currently paralysed in her ...

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...

Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...